CLINICAL_TRIALS
trial_result
· 2020-09-16
Clinical Trial Update: Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea [Phase 2]
Summary
Phase 2 trial update for fentanyl buccal tablets evaluating exercise-induced breakthrough dyspnea in patients with advanced cancers; study completed with result…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 2 | Status: COMPLETED | Results posted: 2020-09-16